COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04110873
Recruitment Status : Terminated (It was hard to find suitable subject due to strict enrollment criteria.)
First Posted : October 1, 2019
Last Update Posted : October 1, 2019
Golden Biotechnology Corporation
Information provided by (Responsible Party):
Cheng-Chung Wei, Chung Shan Medical University

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 25, 2019
Actual Study Completion Date : June 25, 2019